aTyr Pharma, Inc.
General ticker "ATYR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $290.0M (TTM average)
aTyr Pharma, Inc. does not follow the US Stock Market performance with the rate: -25.3%.
Estimated limits based on current volatility of 3.1%: low 0.79$, high 0.84$
Factors to consider:
- Total employees count: 55 as of 2015
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.46$, 1.79$]
- 2026-12-31 to 2027-12-31 estimated range: [0.49$, 1.62$]
Short-term ATYR quotes
Long-term ATYR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.35MM | $0.23MM | $0.19MM |
| Operating Expenses | $55.27MM | $68.15MM | $77.82MM |
| Operating Income | $-54.92MM | $-67.91MM | $-77.63MM |
| Non-Operating Income | $4.52MM | $3.89MM | $3.51MM |
| R&D Expense | $42.29MM | $54.37MM | $60.22MM |
| Income(Loss) | $-50.40MM | $-64.02MM | $-74.12MM |
| Profit(Loss)* | $-50.39MM | $-64.02MM | $-74.11MM |
| Stockholders Equity | $90.66MM | $70.02MM | $67.48MM |
| Assets | $120.65MM | $96.83MM | $94.16MM |
| Operating Cash Flow | $-33.22MM | $-69.12MM | $-61.99MM |
| Capital expenditure | $4.21MM | $0.07MM | $0.08MM |
| Investing Cash Flow | $-20.13MM | $17.23MM | $-5.05MM |
| Financing Cash Flow | $66.23MM | $39.86MM | $66.01MM |
| Earnings Per Share** | $-0.94 | $-0.86 | $-0.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.